It offers analytics-based services that reduce medical costs through data-driven algorithms that detect claims overcharges and recommend or negotiate reimbursement. Its network-based services reduce medical costs through contracted discounts with health care providers, and its payment integrity services reduce medical costs by identifying and removing improper and unnecessary charges paid during the claim.

MultiPlan also provides health benefit plans, which feature reference-based pricing and tools to engage health plan members and providers to make use of benefits before and after care delivery. The company serves national insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, third-party administrators, insurance bill review companies, Taft-Hartley plans and other entities that pay medical bills in the commercial health care, government, workers’ compensation and auto medical markets.

The $9 Citigroup price target tops the $8.75 consensus target. On Friday, the shares were last seen at $5.05.

Zeta Global

This company is in a white-hot business silo and the stock has massive upside potential. Zeta Global Holdings Corp. (NASDAQ: ZETA) operates an omnichannel data-driven cloud platform that provides enterprises with consumer intelligence and marketing automation software in the United States and internationally.

Its Zeta Marketing Platform analyzes billions of structured and unstructured data points to predict consumer intent by leveraging sophisticated machine learning algorithms and the industry’s opted-in data set for omnichannel marketing. The Consumer Data Platform ingests, analyzes and distills disparate data points to generate a single view of a consumer, encompassing identity, profile characteristics, behaviors and purchase intent.

Zeta also offers various types of product suites, such as opportunity explorer, consumer experiences, omnichannel acquisition and identity and data management. In addition, the company provides demand-side platform and website personalization services, and its TruLift offers analysis to uniquely quantify incremental budget that provides continued return on investment.

The Wall Street high $16.50 price target comes from Roth Capital. The consensus target is just $12.25, and the last trade on Friday was reported at $8.58.

Get Our Free Investment Newsletter

I have read, and agree to the Terms of Use

These are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential. While not suited for all investors, they are not penny stocks with absolutely no track record or liquidity, and major Wall Street firms have research coverage.